NATCO PHARMA LIMITED (INDIA)

Herduo

HERDUO contains the Drug / Molecule “LAPATINIB DITOSYLATE”. Herduo belongs to a class of medications called tyrosine kinase inhibitor. Tyrosine kinase is protein on the surface of a cell which sends the signals. Lapatinib blocks the signals from the tyrosine kinase. Blocking the signals they stop the growth of those cancer cells in body.

Details
Specification

Indication

Herduo is used together with another medicine called capecitabine or letrozole to treat a certain type of advanced or metastatic breast cancer that has spread to other parts of the body.

Note

Precaution

Herduo is a prescription drug and should be used under proper medical guidance and advice.
Herduo may cause a condition that affect the heart rhythm.
Herduo is not recommended for use during pregnancy. It may harm an unborn baby. Therefore, it is important to prevent pregnancy while taking this medication.
Herduo may cause Liver Damage

Updated On Oct 19, 2019 by Admin

Strength

250 mg

Packing

1*30 Tablets (Container) & 1*150 Tablets (Container)

Storage

Store between 15°C to 30°C

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Herduo also available as

GLAXO SMITH KLINE

Tykerb-herduo

"Tykerb" contains the Drug / Molecule “Lapatinib Ditosylate”. Tykerb belongs to a class of medications called tyrosine kinase inhibitor. Tyrosine kinase is protein on the surface of a cell which sends the signals. Lapatinib blocks the signals from the tyrosine kinase. By blocking the signals they stop the growth of those cancer cells in body.